仙琚制药：XXXX年半年度财务报告

浙江仙琚制药股份有限公司2010年半年度财务报告（未经审计）股票代码：002332股票简称:仙琚制药披露时间：2010年8月浙江仙琚制药股份有限公司2010年半年度报告1财务报表会合01表单位：人民币元项目注释号期末数项目注释号期末数期初数流动资产：流动负债：货币资金1706,540,176.31短期借款16446,449,015.46495,510,451.06结算备付金向中央银行借款拆出资金吸收存款及同业存放交易性金融资产拆入资金应收票据290,126,444.41交易性金融负债应收账款3236,563,849.39应付票据178,662,920.0011,745,460.00预付款项441,357,780.27应付账款18133,156,683.36111,445,860.48应收保费预收款项1913,902,687.0611,315,196.04应收分保账款卖出回购金融资产款应收分保合同准备金应付手续费及佣金应收利息应付职工薪酬2016,465,780.1220,178,949.14应收股利56,235,144.00应交税费2134,817,425.0424,422,579.17其他应收款614,060,883.64应付利息22816,807.81892,926.49买入返售金融资产应付股利2322,076,490.0014,745,600.00存货7240,873,082.54其他应付款2437,923,216.4638,023,032.05一年内到期的非流动资产应付分保账款其他流动资产保险合同准备金流动资产合计1,335,757,360.56代理买卖证券款代理承销证券款一年内到期的非流动负债2550,000,000.0050,000,000.00其他流动负债流动负债合计764,271,025.31778,280,054.43非流动负债：长期借款非流动资产：应付债券发放贷款及垫款长期应付款可供出售金融资产专项应付款持有至到期投资预计负债长期应收款递延所得税负债长期股权投资841,128,615.78其他非流动负债投资性房地产953,295,166.84非流动负债合计26固定资产10269,726,928.20负债合计764,271,025.31778,280,054.43在建工程1159,093,114.96所有者权益(或股东权益)：工程物资12268,194.40实收资本(或股本)27341,400,000.00341,400,000.00固定资产清理资本公积28575,214,952.60575,214,952.60生产性生物资产减：库存股油气资产专项储备无形资产1352,247,012.11盈余公积2954,522,581.6254,522,581.62开发支出一般风险准备商誉未分配利润3063,312,045.65109,878,332.48长期待摊费用142,116,177.55外币报表折算差额递延所得税资产152,412,968.33归属于母公司所有者权益合计1,034,449,579.871,081,015,866.70其他非流动资产少数股东权益17,324,933.5519,141,546.56非流动资产合计480,288,178.17所有者权益合计1,051,774,513.421,100,157,413.26资产总计1,816,045,538.73负债和所有者权益总计1,816,045,538.731,878,437,467.69会计机构负责人：潘旦杰469,909,427.891,878,437,467.69法定代表人：金敬德主管会计工作的负责人：张琦2,749,695.712,140,424.0053,399,820.4653,990,762.27276,699,410.7443,611,823.37164,548.2737,152,943.07256,470,646.781,408,528,039.8012,639,856.9636,441,737.41109,508,682.02181,040,595.35期初数812,426,521.28合并资产负债表编制单位：浙江仙琚制药股份有限公司2010年6月30日浙江仙琚制药股份有限公司2010年半年度报告2会企01表单位:人民币元项目注释号期末数期初数注释号期末数期初数流动资产：货币资金677,490,911.06778,786,063.30431,914,015.46479,424,545.46交易性金融资产应收票据86,538,302.0796,563,913.00应收账款1193,758,171.51157,724,145.6580,135,588.8158,450,734.92预付款项31,102,587.0127,641,141.367,888,825.234,579,058.96应收利息15,882,812.5718,026,686.15应收股利6,235,144.0029,854,221.4518,010,450.12其他应收款289,431,770.7488,483,405.02797,726.00870,233.59存货211,251,159.08219,524,279.9722,076,490.0014,745,600.00一年内到期的非流动资产22,549,461.0727,536,493.22其他流动资产50,000,000.0050,000,000.00流动资产合计1,295,808,045.471,368,722,948.30661,099,140.59671,643,802.42非流动资产：可供出售金融资产持有至到期投资长期应收款长期股权投资3101,488,615.7897,512,943.07投资性房地产44,716,250.8545,273,121.96固定资产197,748,711.19202,511,517.98在建工程36,938,367.2422,441,603.69工程物资268,194.40164,548.27固定资产清理661,099,140.59671,643,802.42生产性生物资产油气资产341,400,000.00341,400,000.00无形资产37,801,470.9138,243,506.77574,150,977.40574,150,977.40开发支出商誉长期待摊费用278,041.85298,848.1154,522,581.6254,522,581.62递延所得税资产4,092,923.783,299,423.52其他非流动资产87,967,921.86136,751,100.23非流动资产合计423,332,576.00409,745,513.371,058,041,480.881,106,824,659.25资产总计1,719,140,621.471,778,468,461.671,719,140,621.471,778,468,461.67会计机构负责人：潘旦杰未分配利润所有者权益合计负债和所有者权益总计法定代表人：金敬德主管会计工作的负责人：张琦减：库存股专项储备盈余公积一般风险准备负债合计所有者权益(或股东权益)：实收资本(或股本)资本公积预计负债递延所得税负债其他非流动负债非流动负债合计长期借款应付债券长期应付款专项应付款一年内到期的非流动负债其他流动负债流动负债合计非流动负债：应交税费应付利息应付股利其他应付款应付票据应付账款预收款项应付职工薪酬项目流动负债：短期借款交易性金融负债资产负债表编制单位：浙江仙琚制药股份有限公司2010年6月30日浙江仙琚制药股份有限公司2010年半年度报告3会合02表单位：人民币元项目本期数上年同期数一、营业总收入743,528,556.11597,375,852.40其中：营业收入743,528,556.11597,375,852.40利息收入已赚保费手续费及佣金收入二、营业总成本681,293,399.07559,620,524.50其中：营业成本464,413,613.27360,024,675.58利息支出手续费及佣金支出退保金赔付支出净额提取保险合同准备金净额保单红利支出分保费用营业税金及附加4,925,744.923,484,380.66销售费用120,521,841.13104,042,334.60管理费用72,560,303.1765,831,994.32财务费用12,959,241.3720,788,661.96资产减值损失5,912,655.215,448,477.38加：公允价值变动收益（损失以“-”号填列）投资收益（损失以“-”号填列）10,210,816.714,107,055.47其中：对联营企业和合营企业的投资收益10,165,672.713,980,625.47汇兑收益（损失以“-”号填列）三、营业利润（亏损以“-”号填列）72,445,973.7541,862,383.37加：营业外收入2,938,541.376,062,034.35减：营业外支出1,800,554.891,668,534.55其中：非流动资产处置损失272,743.32230,270.69四、利润总额（亏损总额以“-”号填列）73,583,960.2346,255,883.17减：所得税费用19,546,860.0712,322,607.01五、净利润（净亏损以“-”号填列）54,037,100.1633,933,276.16归属于母公司所有者的净利润55,853,713.1738,133,603.19少数股东损益-1,816,613.01-4,200,327.03六、每股收益：（一）基本每股收益0.160.15（二）稀释每股收益0.160.15七、其他综合收益八、综合收益总额54,037,100.1633,933,276.16归属于母公司所有者的综合收益总额55,853,713.1738,133,603.19归属于少数股东的综合收益总额-1,816,613.01-4,200,327.03法定代表人：金敬德主管会计工作的负责人：张琦会计机构负责人：潘旦杰7564321注释号1合并利润表编制单位：浙江仙琚制药股份有限公司2010年1-6月浙江仙琚制药股份有限公司2010年半年度报告4会企02表编制单位：浙江仙琚制药股份有限公司单位：人民币元项目注释号本期数上年同期数一、营业收入1528,027,726.97418,520,920.24减：营业成本1345,361,100.11272,163,119.49营业税金及附加3,644,026.162,488,634.14销售费用47,622,730.0221,795,460.96管理费用58,486,310.7350,414,326.92财务费用10,345,505.1218,679,776.65资产减值损失7,650,309.427,518,226.13加：公允价值变动收益（损失以“-”号填列）投资收益（损失以“-”号填列）210,210,816.714,107,055.47其中：对联营企业和合营企业的投资收益10,165,672.713,980,625.47二、营业利润（亏损以“-”号填列）65,128,562.1249,568,431.42加：营业外收入2,400,870.435,756,420.95减：营业外支出1,389,895.821,313,911.75其中：非流动资产处置净损失272,743.32230,270.69三、利润总额（亏损总额以“-”号填列）66,139,536.7354,010,940.62减：所得税费用12,502,715.1010,691,015.80四、净利润（净亏损以“-”号填列）53,636,821.6343,319,924.82五、每股收益：（一）基本每股收益0.160.17（二）稀释每股收益0.160.17六、其他综合收益七、综合收益总额53,636,821.6343,319,924.82利润表法定代表人：金敬德主管会计